Editorial: GPCRs and Cancer
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-10-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fgene.2017.00162/full |
id |
doaj-fa8b0540abcb452a9ef2671cba5f9b04 |
---|---|
record_format |
Article |
spelling |
doaj-fa8b0540abcb452a9ef2671cba5f9b042020-11-25T01:05:36ZengFrontiers Media S.A.Frontiers in Genetics1664-80212017-10-01810.3389/fgene.2017.00162309243Editorial: GPCRs and CancerSuzie Chen0Suzie Chen1Susan Lehman Cullman Laboratory for Cancer Research, Ernest Marion School of Pharmacy, Rutgers University, Piscataway, NJ, United StatesRutgers Cancer Institute of New Jersey, New Brunswick, NJ, United Stateshttp://journal.frontiersin.org/article/10.3389/fgene.2017.00162/fullPCRcancerexcess ligandtargets for treatmentgenetic predisposition |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Suzie Chen Suzie Chen |
spellingShingle |
Suzie Chen Suzie Chen Editorial: GPCRs and Cancer Frontiers in Genetics PCR cancer excess ligand targets for treatment genetic predisposition |
author_facet |
Suzie Chen Suzie Chen |
author_sort |
Suzie Chen |
title |
Editorial: GPCRs and Cancer |
title_short |
Editorial: GPCRs and Cancer |
title_full |
Editorial: GPCRs and Cancer |
title_fullStr |
Editorial: GPCRs and Cancer |
title_full_unstemmed |
Editorial: GPCRs and Cancer |
title_sort |
editorial: gpcrs and cancer |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Genetics |
issn |
1664-8021 |
publishDate |
2017-10-01 |
topic |
PCR cancer excess ligand targets for treatment genetic predisposition |
url |
http://journal.frontiersin.org/article/10.3389/fgene.2017.00162/full |
work_keys_str_mv |
AT suziechen editorialgpcrsandcancer AT suziechen editorialgpcrsandcancer |
_version_ |
1725193603284729856 |